Kyowa Kirin International plc.

Today, we celebrate International Day of Persons with Disabilities (IDPD). As proud members of PurpleSpace, we’ve been actively engaging in their Learning Hubs, gaining valuable insights and driving meaningful conversations around disability inclusion. This coming year, we’re thrilled to dive deeper into the topic of neurodiversity in the workplace. A big thank you to Daniel Aherne from Adjust - Neurodiversity Understood for helping us kick off this important conversation. Together, we’re committed to fostering a workplace where everyone can thrive. Let’s keep the momentum going and create a world where inclusion isn’t just a goal, but a reality! #KKIMakingPeopleSmile #PurpleSpace #AdjustNeurodiversityUnderstood #IDPD #InclusionMatters #DisabilityInclusion

Hear from Kyowa Kirin's Global Head, Health Economics and Outcomes Research, Angela Williams—following her participation in the recent Medical Affairs Professional Society (MAPS) eCADEMY session on patient engagement in evidence generation. Angela shares her perspective on the importance of active, meaningful and collaborative interactions between patients, patient advocacy groups and researchers, throughout all stages of a clinical study. #MAPSEvents #KKIMakingPeopleSmile

For media and investors We are pleased to announce that Kura Oncology and Kyowa Kirin have entered into a strategic collaboration to accelerate the delivery of innovative therapies that can transform the lives of patients living with acute myeloid leukemia (AML) and other haematologic malignancies. By combining our expertise and resources we look forward to partnering together to make a difference in the fight against these challenging diseases, and ultimately make more people smile. #KKIMakingPeopleSmile

Hear from Kyowa Kirin's Global Outcomes Research Director, Angela Rylands PhD CPyschol—fresh from her expert panel session at #ISPOREurope 2024—as she highlights the vital role of patient partners in shaping clinical outcome assessment (COA) strategies. #KKIMakingPeopleSmile

We're thrilled to announce that our Italian colleagues at Kyowa Kiron S.R.L are moving to a new office space in the vibrant heart of Milan’s business district – SeiMilano Bisceglie! This move marks an exciting new chapter for us as we continue to grow, collaborate, and innovate in one of Milan's most dynamic areas. Our new location is modern and bright, with a flexible layout that encourages collaboration and enhances employee wellbeing, creating a welcoming and stimulating environment. Here’s to new beginnings and a bright future in SeiMilano Bisceglie for our Italian colleagues. #KKIMakingPeopleSmile #NewOffice #SeiMilanoBisceglie #Growth #Innovation

When it comes to co-creating value in our patient focussed medical product development, the most valuable perspective is the patient's. By involving patients early and continuously, as collaborators and partners, our development of clinical outcome assessment (COA) strategies, are more likely to be both scientifically rigorous and patient relevant and ultimately aligned with what truly matters to the people we're trying to help. Going to #ISPOREurope 2024 Barcelona? Join Angela Rylands PhD CPyschol, Global Outcomes Research Director, Kyowa Kirin—and other leading experts from the areas of research, regulatory, and patient advocacy—for an interactive discussion and sharing of diverse perspectives on how to unlock the key to meaningful COAs. Join session 128 on Monday 18th November: https://bit.ly/4ejyHda #KKIMakingPeopleSmile

For Media and Investors As we continue on our journey to deliver against our Vision for 2030 and become a true Japan-based global specialty pharmaceutical company, today we announced that Masashi Miyamoto, Ph.D. will take the role of Chairman and CEO of Kyowa Kirin, after serving as President for the past 7 years. Abdul Mullick, Ph.D., the current Chief International Business Officer (CIBO), will become President and Chief Operating Officer, with the changes expected to come into effect following approval in March 2025. Many congratulations to both Masa and Abdul on their new appointments. #KKIMakingPeopleSmile https://bit.ly/4fqm1C7

Following #InternationalXLHAwarenessDay on 23rd October, Myriam H., Regional Nephrology Franchise Head EMEA at Kyowa Kirin, has been reflecting on the importance of collaboration to aid our understanding of X-linked hypophosphataemia (XLH) and its challenges. At KKI, we are committed to working with the community to better understand #XLH to facilitate earlier diagnosis and improved management: 👉 Through our XLH registry, we collaborated with clinicians to collect evidence from over 1,200 patients across more than 20 countries to better understand the history and trajectory of XLH. 👉 By partnering with the global clinical community, we are able to collect real-world evidence from people living with XLH, recently presenting a breadth of data at the American Society for Bone and Mineral Research (ASBMR) meeting in Toronto, Canada. Read Myriam’s article below to learn more about XLH and the importance collaborations and partnerships in this space📝 #KKIMakingPeopleSmile

Today, we join the global community in recognising #InternationalXLHAwarenessDay! X-linked hypophosphataemia (XLH) is a rare genetic disorder caused by low levels of phosphate. Individuals living with the condition may display a multitude of symptoms including short stature, limb deformities, bone and joint pain, oral abscesses, and hearing loss. These symptoms can have a profound impact on those living with the condition and can lead to a reduced quality of life. Today and every day, KKI is proud to stand with the #XLH patient community. By working together, we can raise vital awareness about the signs, symptoms and the impact on those affected. #KKIMakingPeopleSmile

👉 Did you know that 1 in 20-60,000 people in Europe are estimated to live with X-linked hypophosataemia (XLH)? XLH is a rare genetic disorder caused by low levels of phosphate, which can lead to soft and deformed bones and impaired mobility. Unfortunately, awareness of XLH and the impact it can have on those living with it, is low. At KKI, we’re committed to improving the lives of those affected by #XLH through research, support, and collaboration. As we approach #InternationalXLHAwarenessDay this Wednesday 23rd October, please join us in raising awareness of XLH by sharing this post. #KKIMakingPeopleSmile